NiXEN has co-invested in HT Médica alongside Fremman to support the company's growth in the Spanish diagnostic imaging market.

Information on the Target

HT Médica is one of the leading operators of radiology and diagnostic imaging services in Spain. The company operates 20 diagnostic imaging centers and 2 laboratories strategically located across Andalusia, Castile-La Mancha, Asturias, and Madrid.

HT Médica offers a diverse portfolio of services, including MRI, CT scans, ultrasound, X-rays, and laboratory services. The company has built a strong reputation in the market, evidenced by its extensive experience and leadership in clinical settings.

Industry Overview in Spain

The healthcare sector in Spain, particularly the diagnostic imaging market, has shown significant growth due to advancements in technology and the incr

View Source

Similar Deals

Management Team of Ortopedia Sumisan, S.L. Ortopedia Sumisan, S.L.

2025

Management Buyout / Buy-In (MBO) Medical Prosthetics Spain
Ortopedia Sumisan, S.L. Ortopedia Sumisan, S.L.

2025

Management Buyout / Buy-In (MBO) Medical Supplies Spain
NiXEN Palex

2024

Management Buyout / Buy-In (MBO) Advanced Medical Equipment & Technology (NEC) Spain
Miura Partners HTBA

2024

Management Buyout / Buy-In (MBO) Biotechnology & Medical Research (NEC) Spain
Aminolabs Nutrition Zoka Pharma

2023

Management Buyout / Buy-In (MBO) Pharmaceuticals (NEC) Spain
Abac Capital and Pronokal's management team Pronokal

2023

Management Buyout / Buy-In (MBO) Healthcare Facilities & Services (NEC) Spain

NiXEN

invested in

HT Médica

in 2024

in a Management Buyout / Buy-In (MBO) deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert